Form 4: Director Thomas B. Okray Acquires Flowserve Shares

Flowserve Corporation director Thomas B. Okray acquired 2,573 shares of common stock as part of an annual restricted stock grant.

Summary

• Director Thomas B. Okray received an annual grant of 2,573 shares of Flowserve Corporation (FLS) common stock.
• The transaction occurred on May 14, 2026, at a price of $67.99 per share.
• Following this transaction, the director's total beneficial ownership increased to 13,335 shares.
• The shares are subject to a vesting schedule tied to the earlier of May 14, 2027, or the 2027 annual meeting of shareholders.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Director alignment with shareholder interests through increased equity ownership.

Negatives

• None identified.

Risks

• Vesting of the restricted stock is contingent upon continued service as a director until the 2027 annual meeting.

Future Outlook

The shares are scheduled to vest on May 14, 2027, or upon the date of the 2027 annual meeting of shareholders, whichever occurs first.

Industry Context

StockSavvy.ai notes that annual equity grants to non-employee directors are a standard corporate governance practice in the industrial manufacturing sector to ensure long-term alignment between board members and shareholders.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) as part of annual director compensation is consistent with standard practices for S&P 400 mid-cap industrial companies.
• The vesting period of one year is standard for annual director equity awards.

Corporate Governance

Stakeholder Impact

• Shareholders benefit from increased director equity alignment.

Next Steps

• Vesting of the 2,573 shares on May 14, 2027.

Key Dates

Keywords

Flowserve, FLS, Insider Trading, Form 4, Director Compensation, Equity Grant